Literature DB >> 7980840

Streptokinase antibodies are of clinical importance and they can be measured in half an hour by a simple enzyme-linked immunosorbent assay.

J Brügemann, J van der Meer, V J Bom, K I Lie.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7980840      PMCID: PMC1025494          DOI: 10.1136/hrt.72.2.209-a

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  7 in total

1.  Anti-streptokinase antibodies inhibit fibrinolytic effects of anistreplase in acute myocardial infarction.

Authors:  J Brügemann; J van der Meer; V J Bom; W van der Schaaf; P A de Graeff; K I Lie
Journal:  Am J Cardiol       Date:  1993-08-15       Impact factor: 2.778

2.  Are streptokinase antibodies clinically important?

Authors:  M B Buchalter
Journal:  Br Heart J       Date:  1993-08

3.  Clinical failure of streptokinase due to an unsuspected high titer of antistreptokinase antibody.

Authors:  A S Lew; T Neer; L Rodriguez; I L Geft; P K Shah; W Ganz
Journal:  J Am Coll Cardiol       Date:  1984-07       Impact factor: 24.094

4.  Measurement of antistreptokinase antibodies.

Authors:  U Sigwart; M Grbic; F Bachmann
Journal:  J Am Coll Cardiol       Date:  1985-06       Impact factor: 24.094

5.  A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction.

Authors:  J Brügemann; J van der Meer; B H Takens; H Hillege; K I Lie
Journal:  Br Heart J       Date:  1990-12

6.  Streptokinase neutralisation titres up to 866 days after intravenous streptokinase for acute myocardial infarction.

Authors:  S Patel; S Jalihal; D P Dutka; G K Morris
Journal:  Br Heart J       Date:  1993-08

7.  Rapid enzyme immunoassay of anti-streptokinase antibodies in human plasma.

Authors:  V J Bom; J Brügemann; W van der Schaaf; R T van Wijk; J van der Meer
Journal:  Clin Chim Acta       Date:  1993-09-30       Impact factor: 3.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.